Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
25 April 2019 | Story Igno van Niekerk | Photo Igno van Niekerk
Allon Raiz
Entrepreneurship is the future: Allon Raiz provides tools for tomorrow at recent UFS Business School guest lecture.

Allon Raiz treated staff and students to an entertaining, insightful and thought-provoking session on Lose the business plan: what they don’t teach you about being an entrepreneur on Thursday 10 April 2019 at the Bloemfontein Campus. The University of the Free State (UFS) Business School hosted Raiz for a guest lecture on going beyond the business plan.

Raiz, the founder and CEO of Raizcorp is the host of The Big Small Business Show on Business Day TV. He is also the author of two best-selling entrepreneurial books, and he literally gets down to earth about talking business issues when he takes off his shoes as he takes the stage to deliver a talk.

What they don’t teach you

Raiz started the session by sharing the fact that 96% of small businesses fail within 10 years. From his research and experience, he shared the three main attributes always found when studying successful entrepreneurs: “They see opportunities, take risks and add value.”

He was however clear on the fact that there is no such thing as a typical entrepreneur. “It is not about a set of characteristics, it is about a set of probabilities.”

Effective entrepreneurship education

After sharing his personal journey to entrepreneurial success, Raiz explained that entrepreneurs had different expectations in terms of how much they wanted to earn, and how big they wanted to grow their businesses. Although entrepreneurs come in all shapes and sizes, there are some generic tools which all entrepreneurs can use. These include finding role models, being resilient, and having an internal locus of control. 

The essence of Raiz’s message was that no matter what you want to do, don’t wait and make plans – take action. In short, lose the business plan – start working on the business.

News Archive

DNA sequencer launched at the UFS
2013-11-25

Dr Gansen Pillay, Deputy Chief Executive Officer of the National Research Foundation, explaining to the scholars what will be expected of them.

The University of the Free State (UFS) can now collect immensely valuable data on drug resistance in HIV/Aids and TB with the new DNA sequencer that was launched recently at the International workshop on HIV/AIDS and TB drug resistance at the Bloemfontein Campus.

The DNA sequencer will allow the Free State province to produce viral and bacterial genetic data to fight the local development of HIV/ Aids and TB drug resistance.

The HIV and TB epidemics have expanded very fast and South Africa now has the largest HIV and TB treatment programme in the world, with over 2 million patients on treatment. However, these successful treatment programmes are now being threatened by the appearance of drug resistance.

The Free State province has been at the forefront of fighting HIV drug resistance in South Africa and has one of the most advanced treatment programmes for the management of resistance strains in the country. In addition, researchers at the University of the Free State are leading partners in the Southern African Treatment and Resistance Network (SATuRN; www.bioafrica.net/saturn), a research network that has trained over 2 000 medical officers in the treatment of drug resistance strains.

The Department of Medical Microbiology and Virology in the Medical School at the UFS has partnered with the provincial department of health, the Medical Research Council (MRC) and the Delegation of the European Union to South Africa to fund a dedicated DNA sequencer machine that will be used to generate HIV and TB drug-resistance results. This new machine will enable cutting-edge research to take place, using the data in the province and, importantly, support patients with resistance strains to have access to advanced genotypic testing techniques.

“HIV drug resistance is a very serious problem in South Africa, and the recent advances in DNA testing technology allow clinicians in the province to access drug resistance testing, which enables them to manage patients appropriately who fail treatment, and use the results to cost-effectively extend and improve patients’ lives,” says Dr Cloete van Vuuren, Specialist in Infectious Diseases at the UFS’s Faculty of Health.

Dr Dominique Goedhals, pathologist from the Department of Medical Microbiology and Virology at the UFS, adds: “We have been looking forward to expanding our work with the clinicians and researchers, using DNA sequencing to shed light on the causes and consequences of drug resistance in urban and rural settings in the province.”

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept